ArticleTurkish journal of medical sciences2026
Effects of colchicine on SAH-induced vascular damage in an experimental subarachnoid hemorrhage model.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Subarachnoid hemorrhage (SAH) is a severe cerebrovascular condition associated with high morbidity and mortality. Inflammation and oxidative stress play critical roles in its pathophysiology, especially in the development of secondary vascular damage. This study aimed to evaluate the protective effects of colchicine on vascular integrity and biochemical markers following SAH in an experimental rat model. Materials and methods: Eighteen female Sprague Dawley rats were randomly divided into 3 groups: Control (no SAH), SAH (induced without treatment), and SAH + colchicine (received intraperitoneal colchicine at a dose of 1 mg/kg). SAH was induced by injecting autologous blood into the cisterna magna. Rats were sacrificed 48 h post induction. Biochemical parameters were assessed in serum and brain tissue, and histopathological evaluations were conducted to assess vascular damage. Results: Compared to the untreated SAH group, colchicine significantly reduced serum levels of interleukin-1β, interleukin-6, and tumor necrosis factor-α (p < 0.05). Oxidative stress markers, including total oxidant status and oxidative stress index, decreased, while total antioxidant status showed partial recovery. Thiol-disulfide homeostasis was improved, evidenced by elevated native thiol levels and reduced disulfide/native thiol ratios. Histopathological analyses showed attenuation of endothelial injury and inflammation; however, basilar artery diameter and wall thickness remained statistically unchanged. Conclusion: Colchicine reduced inflammation and oxidative stress markers in an experimental rat model of SAH, offering partial protection against vascular injury. Further studies are needed to evaluate long-term effects and dosing strategies for colchicine as a neuroprotective agent in cerebrovascular injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.